Mullard A. FDA approves 100th monoclonal antibody product. Nat Rev Drug Discov. 2021;20(7):491–5.

Article  CAS  PubMed  Google Scholar 

Pardridge WM. Blood-brain barrier and delivery of protein and gene therapeutics to brain. Front Aging Neurosci. 2020;11:373.

Article  PubMed  PubMed Central  Google Scholar 

Gklinos P, Papadopoulou M, Stanulovic V, Mitsikostas DD, Papadopoulos D. Monoclonal antibodies as neurological therapeutics. Pharmaceuticals. 2021;14(2):92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Garg A, Balthasar JP. Investigation of the influence of FcRn on the distribution of IgG to the brain. AAPS J. 2009;11(3):553–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chang HY, Morrow K, Bonacquisti E, Zhang W, Shah DK. Antibody pharmacokinetics in rat brain determined using microdialysis. MAbs. 2018;10(6):843–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Q, Delva L, Weinreb PH, Pepinsky RB, Graham D, Veizaj E, et al. Monoclonal antibody exposure in rat and cynomolgus monkey cerebrospinal fluid following systemic administration. Fluids Barriers CNS. 2018;15(1):1–10.

Article  Google Scholar 

Naseri Kouzehgarani G, Feldsien T, Engelhard HH, Mirakhur KK, Phipps C, Nimmrich V, et al. Harnessing cerebrospinal fluid circulation for drug delivery to brain tissues. Adv Drug Deliv Rev. 2021;173:20–59.

Article  CAS  PubMed  Google Scholar 

Chowdhury EA, Meno-Tetang G, Chang HY, Wu S, Huang HW, Jamier T, et al. Current progress and limitations of AAV mediated delivery of protein therapeutic genes and the importance of developing quantitative pharmacokinetic/pharmacodynamic (PK/PD) models. Adv Drug Deliv Rev. 2021;170:214–37.

Article  CAS  PubMed  Google Scholar 

Yadav DB, Maloney JA, Wildsmith KR, Fuji RN, Meilandt WJ, Solanoy H, et al. Widespread brain distribution and activity following i.c.v. infusion of anti-beta-secretase (BACE1) in nonhuman primates. Br J Pharmacol. 2017;174(22):4173–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pizzo ME, Wolak DJ, Kumar NN, Brunette E, Brunnquell CL, Hannocks MJ, et al. Intrathecal antibody distribution in the rat brain: Surface diffusion, perivascular transport and osmotic enhancement of delivery. J Physiol. 2018;596(3):445–75.

Article  CAS  PubMed  Google Scholar 

Stemmler H-J, Schmitt M, Willems A, Bernhard H, Harbeck N, Heinemann V. Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood–brain barrier. Anticancer Drugs. 2007;18(1):23–8.

Article  CAS  PubMed  Google Scholar 

Logovinsky V, Satlin A, Lai R, Swanson C, Kaplow J, Osswald G, et al. Safety and tolerability of BAN2401-a clinical study in Alzheimer’s disease with a protofibril selective Aβ antibody. Alzheimer’s Res Ther. 2016;8(1):1–10.

Article  Google Scholar 

Van De Vyver AJ, Walz AC, Heins MS, Abdolzade-Bavil A, Kraft TE, Waldhauer I, et al. Investigating brain uptake of a non-targeting monoclonal antibody after intravenous and intracerebroventricular administration. Front Pharmacol. 2022;13:958543.

Article  PubMed  Google Scholar 

Chang HY, Wu S, Meno-Tetang G, Shah DK. A translational platform PBPK model for antibody disposition in the brain. J Pharmacokinet Pharmacodyn. 2019;46(4):319–38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chang H-Y, Wu S, Chowdhury EA, Shah DK. Towards a translational physiologically-based pharmacokinetic (PBPK) model for receptor-mediated transcytosis of anti-transferrin receptor monoclonal antibodies in the central nervous system. J Pharmacokinet Pharmacodyn. 2022;49(3):337–62.

Article  CAS  PubMed  Google Scholar 

Bloomingdale P, Bumbaca-Yadav D, Sugam J, Grauer S, Smith B, Antonenko S, et al. PBPK-PD modeling for the preclinical development and clinical translation of tau antibodies for Alzheimer’s disease. Front Pharmacol. 2022;13:867457.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu S, Le Prieult F, Phipps CJ, Mezler M, Shah DK. PBPK model for antibody disposition in mouse brain: validation using large-pore microdialysis data. J Pharmacokinet Pharmacodyn. 2022;49(6):579–92.

Article  CAS  PubMed  Google Scholar 

Chowdhury EA, Ahuja M, Wu S, Liu S, Huang HW, Kumar M, et al. Pharmacokinetics of AAV9 mediated trastuzumab expression in rat brain following systemic and local administration. J Pharm Sci. 2023;113(1):131–40.

Article  PubMed  Google Scholar 

Nedelman JR, Gibiansky E, Lau DT. Applying Bailer’s method for AUC confidence intervals to sparse sampling. Pharm Res. 1995;12:124–8.

Article  CAS  PubMed  Google Scholar 

Dreha-Kulaczewski S, Joseph AA, Merboldt K-D, Ludwig H-C, Gärtner J, Frahm J. Identification of the upward movement of human CSF in vivo and its relation to the brain venous system. J Neurosci. 2017;37(9):2395–402.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dreha-Kulaczewski S, Konopka M, Joseph AA, Kollmeier J, Merboldt K-D, Ludwig H-C, et al. Respiration and the watershed of spinal CSF flow in humans. Sci Rep. 2018;8(1):5594.

Article  ADS  PubMed  PubMed Central  Google Scholar 

Elbert DL, Patterson BW, Lucey BP, Benzinger TL, Bateman RJ. Importance of CSF-based Aβ clearance with age in humans increases with declining efficacy of blood-brain barrier/proteolytic pathways. Commun Biol. 2022;5(1):98.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lam MA, Hemley SJ, Najafi E, Vella NG, Bilston LE, Stoodley MA. The ultrastructure of spinal cord perivascular spaces: Implications for the circulation of cerebrospinal fluid. Sci Rep. 2017;7(1):12924.

Article  ADS  PubMed  PubMed Central  Google Scholar 

Noguchi Y, Kato M, Ozeki K, Ishigai M. Pharmacokinetics of an intracerebroventricularly administered antibody in rats. MAbs. 2017;9(7):1210–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Spires-Jones TL, Attems J, Thal DR. Interactions of pathological proteins in neurodegenerative diseases. Acta Neuropathol. 2017;134(2):187–205.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Southwell AL, Patterson PH. Antibody therapy in neurodegenerative disease. Rev Neurosci. 2010;21(4):273–88.

Article  CAS  PubMed  Google Scholar 

Bender B, Leipold DD, Xu K, Shen B-Q, Tibbitts J, Friberg LE. A mechanistic pharmacokinetic model elucidating the disposition of trastuzumab emtansine (T-DM1), an antibody–drug conjugate (ADC) for treatment of metastatic breast cancer. AAPS J. 2014;16:994–1008.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thakker DR, Weatherspoon MR, Harrison J, Keene TE, Lane DS, Kaemmerer WF, et al. Intracerebroventricular amyloid-β antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice. Proc Natl Acad Sci. 2009;106(11):4501–6.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med. 2012;4(147):147ra11.

Article  Google Scholar 

Foley CP, Nishimura N, Neeves KB, Schaffer CB, Olbricht WL. Real-time imaging of perivascular transport of nanoparticles during convection-enhanced delivery in the rat cortex. Ann Biomed Eng. 2012;40(2):292–303.

Article  PubMed  Google Scholar 

Wolak DJ, Thorne RG. Diffusion of macromolecules in the brain: implications for drug delivery. Mol Pharm. 2013;10(5):1492–504.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mestre H, Tithof J, Du T, Song W, Peng W, Sweeney AM, et al. Flow of cerebrospinal fluid is driven by arterial pulsations and is reduced in hypertension. Nat Commun. 2018;9(1):4878.

Article  ADS  PubMed  PubMed Central  Google Scholar 

Tithof J, Kelley DH, Mestre H, Nedergaard M, Thomas JH. Hydraulic resistance of periarterial spaces in the brain. Fluids Barriers CNS. 2019;16(1):19.

Article  PubMed  PubMed Central  Google Scholar 

Jessen NA, Munk AS, Lundgaard I, Nedergaard M. The glymphatic system: a beginner’s guide. Neurochem Res. 2015;40(12):2583–99.

Article  CAS  PubMed  PubMed Central  Google Scholar